Literature DB >> 28516167

Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis.

Dinesh Khanna1, Daniel E Furst2, Philip J Clements2, Yannick Allanore3, Murray Baron4, Lazlo Czirjak5, Oliver Distler6, Ivan Foeldvari7, Masataka Kuwana8, Marco Matucci-Cerinic9, Maureen Mayes10, Thomas Medsger11, Peter A Merkel12, Janet E Pope13, James R Seibold14, Virginia Steen15, Wendy Stevens16, Christopher P Denton17.   

Abstract

The modified Rodnan skin score (mRSS) is a measure of skin thickness and is used as a primary or secondary outcome measure in clinical trials of systemic sclerosis (scleroderma). This state-of-art review provides a historical perspective of the development of the mRSS, summarizes the performance of mRSS as an outcome measure, provides guidance on assessing mRSS, and makes recommendations for incorporation of the mRSS into clinical trials.

Entities:  

Year:  2017        PMID： 28516167      PMCID： PMC5431585          DOI： 10.5301/jsrd.5000231

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN： 2397-1983


  31 in total

1.  Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database.

Authors:  Britta Maurer; Nicole Graf; Beat A Michel; Ulf Müller-Ladner; László Czirják; Christopher P Denton; Alan Tyndall; Carola Metzig; Vivian Lanius; Dinesh Khanna; Oliver Distler
Journal:  Ann Rheum Dis       Date:  2014-06-30       Impact factor: 19.103

2.  Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma.

Authors:  Robyn T Domsic; Tatiana Rodriguez-Reyna; Mary Lucas; Noreen Fertig; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2010-08-02       Impact factor: 19.103

3.  The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.

Authors:  Peter A Merkel; Sibel Z Aydin; Maarten Boers; Haner Direskeneli; Karen Herlyn; Philip Seo; Ravi Suppiah; Gunnar Tomasson; Raashid A Luqmani
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

Review 4.  Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysis.

Authors:  Vincent Sobanski; Luc Dauchet; Guillaume Lefèvre; Marc Lambert; Sandrine Morell-Dubois; Thierno Sy; Eric Hachulla; Pierre-Yves Hatron; David Launay; Sylvain Dubucquoi
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

5.  Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.

Authors:  Dinesh Khanna; Christopher P Denton; Angelika Jahreis; Jacob M van Laar; Tracy M Frech; Marina E Anderson; Murray Baron; Lorinda Chung; Gerhard Fierlbeck; Santhanam Lakshminarayanan; Yannick Allanore; Janet E Pope; Gabriela Riemekasten; Virginia Steen; Ulf Müller-Ladner; Robert Lafyatis; Giuseppina Stifano; Helen Spotswood; Haiyin Chen-Harris; Sebastian Dziadek; Alyssa Morimoto; Thierry Sornasse; Jeffrey Siegel; Daniel E Furst
Journal:  Lancet       Date:  2016-05-05       Impact factor: 79.321

6.  A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onset.

Authors:  Fabian A Mendoza; Sarah J Nagle; Jason B Lee; Sergio A Jimenez
Journal:  J Rheumatol       Date:  2012-04-01       Impact factor: 4.666

7.  Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis.

Authors:  Eugene Y Kissin; Peter A Merkel; Robert Lafyatis
Journal:  Arthritis Rheum       Date:  2006-11

8.  Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

Authors:  P J Clements; P A Lachenbruch; J R Seibold; B Zee; V D Steen; P Brennan; A J Silman; N Allegar; J Varga; M Massa
Journal:  J Rheumatol       Date:  1993-11       Impact factor: 4.666

9.  D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis.

Authors:  V D Steen; T A Medsger; G P Rodnan
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

10.  Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis.

Authors:  Rucsandra Dobrota; Britta Maurer; Nicole Graf; Suzana Jordan; Carina Mihai; Otylia Kowal-Bielecka; Yannick Allanore; Oliver Distler
Journal:  Ann Rheum Dis       Date:  2016-03-25       Impact factor: 19.103
View more
  98 in total

1.  Miniaturized electromechanical devices for the characterization of the biomechanics of deep tissue.

Authors:  Enming Song; Zhaoqian Xie; Wubin Bai; Haiwen Luan; Bowen Ji; Xin Ning; Yu Xia; Janice Mihyun Baek; Yujin Lee; Raudel Avila; Huang-Yu Chen; Jae-Hwan Kim; Surabhi Madhvapathy; Kuanming Yao; Dengfeng Li; Jingkun Zhou; Mengdi Han; Sang Min Won; Xinyuan Zhang; Daniel J Myers; Yongfeng Mei; Xu Guo; Shuai Xu; Jan-Kai Chang; Xinge Yu; Yonggang Huang; John A Rogers
Journal:  Nat Biomed Eng       Date:  2021-05-27       Impact factor: 25.671

2.  Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.

Authors:  Jie Tang; Ling Lei; Jie Pan; Cheng Zhao; Jing Wen
Journal:  Rheumatol Int       Date:  2018-05-30       Impact factor: 2.631

3.  Invited Response on: Comments on "Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study".

Authors:  Marco Pignatti; Amelia Spinella; Emanuele Cocchiara; Giulia Boscaini; Irene Laura Lusetti; Giorgia Citriniti; Federica Lumetti; Giacomo Setti; Massimo Dominici; Carlo Salvarani; Giorgio De Santis; Dilia Giuggioli
Journal:  Aesthetic Plast Surg       Date:  2020-11-03       Impact factor: 2.326

Review 4.  Mitochondria, Aging, and Cellular Senescence: Implications for Scleroderma.

Authors:  Marta Bueno; Anna Papazoglou; Eleanor Valenzi; Mauricio Rojas; Robert Lafyatis; Ana L Mora
Journal:  Curr Rheumatol Rep       Date:  2020-06-19       Impact factor: 4.592

5.  Translational optical coherence elastography for assessment of systemic sclerosis.

Authors:  Chih-Hao Liu; Shervin Assassi; Sam Theodore; Christopher Smith; Alexander Schill; Manmohan Singh; Salavat Aglyamov; Chandra Mohan; Kirill V Larin
Journal:  J Biophotonics       Date:  2019-08-08       Impact factor: 3.207

6.  Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.

Authors:  Dinesh Khanna; Cathie Spino; Sindhu Johnson; Lorinda Chung; Michael L Whitfield; Christopher P Denton; Veronica Berrocal; Jennifer Franks; Bhavan Mehta; Jerry Molitor; Virginia D Steen; Robert Lafyatis; Robert W Simms; Anna Gill; Suzanne Kafaja; Tracy M Frech; Vivien Hsu; Robyn T Domsic; Janet E Pope; Jessica K Gordon; Maureen D Mayes; Elena Schiopu; Amber Young; Nora Sandorfi; Jane Park; Faye N Hant; Elana J Bernstein; Soumya Chatterjee; Flavia V Castelino; Ali Ajam; Yue Wang; Tammara Wood; Yannick Allanore; Marco Matucci-Cerinic; Oliver Distler; Ora Singer; Erica Bush; David A Fox; Daniel E Furst
Journal:  Arthritis Rheumatol       Date:  2019-12-10       Impact factor: 10.995

7.  Anti-vinculin antibodies in scleroderma (SSc): a potential link between autoimmunity and gastrointestinal system involvement in two SSc cohorts.

Authors:  Yossra Suliman; Suzanne Kafaja; Sunny J Oh; Mohamed Alemam; Gianluca Bagnato; Giuseppina Abignano; Ram Raj Singh; Gillian Barlow; Xiaochen Liu; Isela Valera; Walter Morales; Ali Rezaie; Mark Pimentel; Francesco Del Galdo; Daniel E Furst
Journal:  Clin Rheumatol       Date:  2020-11-24       Impact factor: 2.980

8.  Increased serum uric acid levels are associated with digital ulcers in patients with systemic sclerosis.

Authors:  Eunsung Kim; Han-Na Lee; Yun-Kyung Kim; Geun-Tae Kim; Min Wook So; Eunyoung Ahn; Dong Hyun Sohn; Seung-Geun Lee
Journal:  Rheumatol Int       Date:  2019-01-17       Impact factor: 2.631

9.  Predictors of Hand Contracture in Early Systemic Sclerosis and the Effect on Function: A Prospective Study of the GENISOS Cohort.

Authors:  Maryam Buni; Joyce Joseph; Claudia Pedroza; Sam Theodore; Deepthi Nair; Terry A McNearney; Hilda T Draeger; John D Reveille; Shervin Assassi; Maureen D Mayes
Journal:  J Rheumatol       Date:  2019-02-01       Impact factor: 4.666

Review 10.  Drugs in phase I and phase II clinical trials for systemic sclerosis.

Authors:  Melody P Chung; Lorinda Chung
Journal:  Expert Opin Investig Drugs       Date:  2020-03-25       Impact factor: 6.206
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.